Okomera
We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity
Okomera
Okomera provides automated 3D organoid screening technology to improve preclinical study predictability and enable personalized medicine development.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Advanced microscopy and imaging equipment for high-resolution organoid analysis.
Liquid handling systems for automated reagent dispensing and sample preparation.
Cloud computing resources for processing large datasets generated from AI-driven analysis.
Service Requirements
Consulting services for optimizing organoid culture protocols and assay development.
Training programs for lab personnel on operating and maintaining the microfluidic screening platform.
Regulatory compliance support for clinical translation of 3D organoid screening results.
Infrastructure Requirements
High-performance computing infrastructure for AI model training and inference.
Secure data storage solutions for managing patient-derived organoid data.
Automated environmental control systems for maintaining optimal organoid culture conditions.
Talent Requirements
Bioengineers with expertise in microfluidics and 3D cell culture.
Data scientists with experience in image analysis and machine learning.
Assay development scientists with knowledge of preclinical drug screening methodologies.
AI Insights
Growth Trajectory
Okomera's recent fundraise and focus on innovative screening technologies suggest high growth potential in the personalized medicine market.
Market Opportunity
Okomera's technology addresses a market gap in scalable CRISPR screening in 3D patient-derived organoids, positioning them for rapid adoption in oncology research.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats